Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T03:40:01.089Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevention of Clostridium difficile Infection: A Systematic Survey of Clinical Practice Guidelines

Published online by Cambridge University Press:  07 June 2016

Lyubov Lytvyn ,
Dominik Mertz ,
Behnam Sadeghirad ,
Faisal Alaklobi ,
Anna Selva ,
Pablo Alonso-Coello  and
Bradley C. Johnston
Lyubov Lytvyn
Affiliation:
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada Systematic Overviews through advancing Research Technology (SORT), Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada
Dominik Mertz
Affiliation:
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada Department of Medicine, McMaster University, Hamilton, Canada Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, Canada
Behnam Sadeghirad
Affiliation:
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada Regional Knowledge Hub and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Faisal Alaklobi
Affiliation:
Department of Pediatric Infectious Disease, King Saud Medical City, Riyadh, Saudi Arabia
Anna Selva
Affiliation:
Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute San Pau (IIB Sant Pau), Barcelona, Spain CIBER de Epidemiologia y Salud Publica, Barcelona, Spain
Pablo Alonso-Coello
Affiliation:
Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute San Pau (IIB Sant Pau), Barcelona, Spain CIBER de Epidemiologia y Salud Publica, Barcelona, Spain
Bradley C. Johnston*
Affiliation:
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada Systematic Overviews through advancing Research Technology (SORT), Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
*
Address correspondence to Bradley C. Johnston, PhD, The Hospital for Sick Children Research Institute, Peter Gilgan Centre for Research and Learning, 686 Bay St, Rm 11.9859 West, Toronto, ON, Canada, M5G 0A4 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

BACKGROUND

Clostridium difficile infection (CDI) is the most common cause of hospital-acquired infectious diarrhea.

OBJECTIVE

To analyze the methodological quality, content, and supporting evidence among clinical practice guidelines (CPGs) on CDI prevention.

DESIGN AND SETTING

We searched medical databases and gray literature for CPGs on CDI prevention published January 2004-January 2015. Three reviewers independently screened articles and rated CPG quality using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument, composed of 23 items, rated 1–7, within 6 domains. We reported each domain score as a percentage of its maximum possible score and standardized range. We summarized recommendations, extracted their supporting articles, and rated individually the level of evidence using the Oxford Centre for Evidence-Based Medicine Levels of Evidence.

RESULTS

Of 2,578 articles screened, 5 guidelines met inclusion criteria. Median AGREE II scores and interquartile ranges were: clarity of presentation, 75.9% (75.9%–79.6%); scope and purpose, 74.1% (68.5%–85.2%); editorial independence, 63.9% (47.2%–66.7%); applicability, 43.1% (19.4%–55.6%); stakeholder involvement, 40.7% (38.9%–44.4%); and rigor of development, 18.1% (17.4%–35.4%). CPGs addressed several common strategies for CDI prevention, including antibiotic stewardship, hypochlorite solutions, probiotic prophylaxis, and bundle strategies. Recommendations were often not consistent with evidence, and most were based on low-level studies.

CONCLUSION

CPGs did not adhere well to AGREE II reporting standards. Furthermore, there was limited transparency in moving from evidence to recommendations. CDI prevention CPGs need to better adhere to AGREE-II and be transparent in moving from evidence to recommendations, and recommendations need to be consistent with available evidence.

Infect Control Hosp Epidemiol 2016;37:901–908

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 8 , August 2016 , pp. 901 - 908
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Dubberke, ER, Butler, AM, Reske, KA, et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14:1031–1038.CrossRefGoogle ScholarPubMed
2. Chitnis, AS, Holzbauer, SM, Belflower, RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013;173:1359–1367.Google Scholar
3. Hebert, C, Du, H, Peterson, LR, Robicsek, A. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013;34:407–414.Google Scholar
4. Ricciardi, R, Rothenberger, DA, Madoff, RD, Baxter, NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624–631.Google Scholar
5. Freeman, J, Bauer, MP, Baines, SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23:529–549.Google Scholar
6. Louie, TJ, Miller, MA, Crook, DW, et al. Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc 2013;61:222–230.Google Scholar
7. Stevens, V, Dumyati, G, Fine, LS, Fisher, SG, van Wijngaarden, E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53:42–48.CrossRefGoogle ScholarPubMed
8. Hensgens, MP, Goorhuis, A, Dekkers, OM, Kuijper, EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012;67:742–748.Google Scholar
9. Slimings, C, Riley, TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014;69:881–891.CrossRefGoogle ScholarPubMed
10. Ghantoji, SS, Sail, K, Lairson, DR, DuPont, HL, Garey, KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010;74:309–318.Google Scholar
11. Nanwa, N, Kendzerska, T, Krahn, M, et al. The economic impact of Clostridium difficile infection: a systematic review. Am J Gastroenterol 2015;110:511–519.Google Scholar
12. Sydnor, ERM, Perl, TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011;24:141–173.Google Scholar
13. Field, MJ, Lohr, KN. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990.Google Scholar
14. Hayward, RA, Wilson, MC, Tunis, SR, Bass, EB, Guyatt, G. Users’ guides to the medical literature, VIII: how to use clinical practice guidelines, A: are the recommendations valid? JAMA 1995;274:570–574.Google Scholar
15. Shaneyfelt, TM, Centor, RM. Reassessment of clinical practice guidelines: go gently into that good night. JAMA 2009;301:868–869.Google Scholar
16. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003;12:18–23.Google Scholar
17. Brouwers, MC, Kho, ME, Browman, GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839–E842.Google Scholar
18. Carrico, RM, Bryant, K, Lessa, F, Limbago, B, Litz Fauerbach, L, Marx, JF. Guide to preventing Clostridium difficile infections. APIC website. http://apic.org/Resource_/EliminationGuideForm/e3a85b7e-7ad8-4ab6-9892-54aef516cf10/File/2013CDiffFinal.pdf. Published 2013. Accessed February 14, 2015.Google Scholar
19. Hawkey, P, Bain, L, Borriello, P, et al. Clostridium difficile infection: how to deal with the problem. Public Health England and Department of Health 2008.Google Scholar
20. OCEBM Working Group. The Oxford Levels of Evidence 2. Oxford Centre for Evidence-Based Medicine website. http://www.cebm.net/index.aspx?o=5653. Published 2011. Accessed February 14, 2015.Google Scholar
21. Howick, J, Chalmers, I, Glasziou, P, et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence (background document). Oxford Centre for Evidence-Based Medicine website. http://www.cebm.net/index.aspx?o=5653. Published 2011. Accessed April 21, 2016.Google Scholar
22. Cohen, J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213.Google Scholar
23. Acuña-Izcaray, A, Sánchez-Angarita, E, Plaza, V, et al. Quality assessment of asthma clinical practice guidelines: a systematic appraisal. Chest 2013;144:390–397.Google Scholar
24. Koch, GG. Intraclass correlation coefficient. Ency Stat Sci 1982.Google Scholar
25. Kramer, MS, Feinstein, AR. Clinical biostatistics, LIV: the biostatistics of concordance. Clin Pharmacol Ther 1981;29:111–123.CrossRefGoogle ScholarPubMed
26. Surawicz, CM, Brandt, LJ, Binion, DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478–498.Google Scholar
27. Vonberg, RP, Kuijper, E, Wilcox, M, et al. Infection control measures to limit the spread of Clostridium difficile . Clin Microbiol Infect 2008;14:2–20.Google Scholar
28. Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control 2014;35:628–645.Google Scholar
29. Debast, S, Bauer, M, Kuijper, E. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014;20:1–26.CrossRefGoogle ScholarPubMed
30. Steinberg, E, Greenfield, S, Mancher, M, Wolman, DM, Graham, R. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press, 2011.Google Scholar
31. Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children. Cochrane Database Syst Rev 2013;5:CD006095.Google Scholar
32. Guyatt, G, Akl, EA, Hirsh, J, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 2010;152:738–741.Google Scholar
33. Eliopoulos, GM, Harris, AD, Bradham, DD, et al. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 2004;38:1586–1591.CrossRefGoogle Scholar
34. Stone, SP, Cooper, BS, Kibbler, CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007;7:282–288.Google Scholar
35. Turner, T, Misso, M, Harris, C, Green, S. Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci 2008;3:45.Google Scholar
36. Kung, J, Miller, RR, Mackowiak, PA. Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress. Arch Intern Med 2012;172:1628–1633.CrossRefGoogle ScholarPubMed
37. Alonso-Coello, P, Irfan, A, Solà, I, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 2010;19:e58.Google Scholar
38. Gagliardi, AR, Brouwers, MC. Do guidelines offer implementation advice to target users? A systematic review of guideline applicability. BMJ Open 2015;5:e007047.Google Scholar
39. Al-Ansary, LA, Tricco, AC, Adi, Y, et al. A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. PLOS ONE 2013;8:e53744.CrossRefGoogle ScholarPubMed
40. Hsu, J, Abad, C, Dinh, M, Safdar, N. Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence. Am J Gastroenterol 2010;105:2327–2339.Google Scholar
41. Khanafer, N, Voirin, N, Barbut, F, Kuijper, E, Vanhems, P. Hospital management of Clostridium difficile infection: a review of the literature. J Hosp Infect 2015;90:91–101.Google Scholar
42. Brozek, J, Akl, E, Falck-Ytter, Y, et al. 046 Guideline development tool (GDT)—web-based solution for guideline developers and authors of systematic reviews. BMJ Qual Saf 2013;22:A26.Google Scholar
43. Shekelle, P, Woolf, S, Grimshaw, J, Schunemann, H, Eccles, M. Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implement Sci 2012;7:62.Google Scholar
44. Browman, GP, Somerfield, MR, Lyman, GH, Brouwers, MC. When is good, good enough? Methodological pragmatism for sustainable guideline development. Implement Sci 2015;10:222.Google Scholar
45. Andrews, J, Guyatt, G, Oxman, AD, et al. GRADE guidelines, 14: going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719–725.Google Scholar
46. Tricoci, P, Allen, JM, Kramer, JM, Califf, RM, Smith, SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831–841.Google Scholar
Supplementary material: File

Lytvyn supplementary material

Tables S1-S8

Download Lytvyn supplementary material(File)
File 52.5 KB